• COVID-19
  • Allergies and Infant Formula
  • Pharmacology
  • Telemedicine
  • Drug Pipeline News
  • Influenza
  • Allergy, Immunology, and ENT
  • Autism
  • Cardiology
  • Emergency Medicine
  • Endocrinology
  • Adolescent Medicine
  • Gastroenterology
  • Infectious disease
  • Nutrition
  • Neurology
  • Obstetrics-Gynecology & Women's Health
  • Developmental/Behavioral Disorders
  • Practice Improvement
  • Gynecology
  • Respiratory
  • Dermatology
  • Diabetes
  • Mental Health
  • Oncology
  • Psychiatry
  • Animal Allergies
  • Alcohol Abuse
  • Rheumatoid Arthritis
  • Sexual Health
  • Pain

Vitamin D deficiency is prevalent among asthmatic African-Americans

Article

Investigators examined the prevalence of vitamin D insufficiency and deficiency among urban African-American youngsters with asthma compared with their African-American peers without asthma.

Investigators examined the prevalence of vitamin D insufficiency and deficiency among urban African-American youngsters with asthma compared with their African-American peers without asthma. They conducted the study at an urban pediatric medical center in Washington, DC, in 92 asthmatic but otherwise healthy children from 6 to 20 years old who had physician-diagnosed asthma for longer than a year. The control participants were 21 children from 6 to 9 years of age with no history of asthma.

Investigators performed a direct enzyme-linked immunosorbent assay on plasma (from cases) or serum (from control participants) to measure D2 and D3 isoforms of 25-hydroxyvitamin D; they defined insufficiency as less than 30 ng/mL and deficiency as less than 20 ng/mL. After adjusting for age, sex, body mass index percentile, and season of sampling, the median vitamin D level of those with asthma was significantly lower than that of the control participants without asthma. Furthermore, the prevalence of vitamin D insufficiency was significantly greater among cases than controls (86% vs 19%). Investigators observed a similar association for vitamin D deficiency: 54% versus 5% (Freishtat RJ, et al. J Pediatr. 2010;156[6]:948-952).

Commentary

Related Videos
Donna Hallas, PhD, CPNP, PPCNP-BC, PMHS, FAANP, FAAN
Scott Ceresnak, MD
Scott Ceresnak, MD
Importance of maternal influenza vaccination recommendations
Reducing HIV reservoirs in neonates with very early antiretroviral therapy | Deborah Persaud, MD
Samantha Olson, MPH
Deborah Persaud, MD
Ari Brown, MD, FAAP | Pediatrician and CEO of 411 Pediatrics; author, baby411 book series; chief medical advisor, Kabrita USA.
© 2024 MJH Life Sciences

All rights reserved.